Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Surgery Partners Inc. (SGRY:NASDAQ), powered by AI.
Surgery Partners Inc. is currently trading at $15.14. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Surgery Partners Inc. on Alpha Lenz.
Surgery Partners Inc.'s P/E ratio is -24.7.
“Surgery Partners Inc. trades at a P/E of -24.7 (undervalued) with modest ROE of -4.4%.”
Ask for details →Surgery Partners Inc. is a prominent healthcare services provider specializing in surgical facilities across the United States. The company operates a network of ambulatory surgical centers (ASCs), hospitals, and physician practices, emphasizing outpatient surgical procedures. Surgery Partners Inc. focuses on delivering high-quality care by collaborating with healthcare practitioners and leveraging advanced medical technologies. The company's facilities serve a broad array of surgical disciplines, including orthopedics, ophthalmology, and gastroenterology, ensuring comprehensive healthcare solutions. The significance of Surgery Partners Inc. in the financial market lies in its role in the rapidly growing outpatient care sector, which favors cost-effectiveness and adaptability compared to traditional hospital settings. As healthcare trends evolve towards more specialized and less invasive procedures, Surgery Partners Inc. stands out as a key player, providing innovative solutions to meet patient and market demands. The company's nationwide presence and strategic partnerships contribute to its robust market position, rendering it an essential component within the broader healthcare services industry.
“Surgery Partners Inc. trades at a P/E of -24.7 (undervalued) with modest ROE of -4.4%.”
Ask for details →Surgery Partners Inc. (ticker: SGRY) is a company listed on NASDAQ in the Healthcare sector (Medical Care Facilities). It has approximately 15,000 employees. Market cap is $1.9B.
The current price is $15.14 with a P/E ratio of -24.72x and P/B of 1.12x.
ROE is -4.45% and operating margin is 14.23%. Annual revenue is $3.3B.